Biodegradable gelatin microspheres enhance the neuroprotective potency of osteopontin via quick and sustained release in the post-ischemic brain

Yinchuan Jin, In Yong Kim, Il Doo Kim, Hye Kyung Lee, Jin Young Park, Pyung Lim Han, Kyekyoon Kevin Kim, Hyungsoo Choi, Ja Kyeong Lee

Research output: Contribution to journalArticlepeer-review

48 Scopus citations


Gelatin microspheres (GMSs) are widely used as drug carriers owing to their excellent biocompatibilities and toxicologically safe degradation products. The drug release profile is easily tailored by controlling the cross-linking density and surface-to-volume ratio, i.e. size, of the GMS. In this study, we employed GMSs which are 25 μm in diameter and cross-linked with 0.03125% glutaraldehyde, to enable rapid initial and a subsequent sustained release. Therapeutic potency of human recombinant osteopontin (rhOPN) with or without encapsulation into GMSs was investigated after administrating them to rat stroke model (Sprague-Dawley; middle cerebral artery occlusion, MCAO). The administration of rhOPN/GMS (100 ng/100 μg) at 1 h post-MCAO reduced the mean infarct volume by 81.8% of that of the untreated MCAO control and extended the therapeutic window at least to 12 h post-MCAO, demonstrating a markedly enhanced therapeutic potency for the use of OPN in the post-ischemic brain. Scanning electron microscopy micrographs revealed that GMSs maintained the three-dimensional shape for more than 5 days in normal brain but were degraded rapidly in the post-ischemic brain, presumably due to high levels of gelatinase induction. After encapsulation with GMS, the duration of OPN release was markedly extended; from the period of 2 days to 5 days in normal brain, and from 2 days to 4 days in the post-ischemic brain; these encompass the critical period for recovery processes, such as vascularization, and controlling inflammation. Together, these results indicate that GMS-mediated drug delivery has huge potential when it was used in the hyperacute period in the post-ischemic brain.

Original languageEnglish
Pages (from-to)3126-3135
Number of pages10
JournalActa Biomaterialia
Issue number7
StatePublished - Jul 2014

Bibliographical note

Funding Information:
This work was financially supported by Research Grants ( NRF-220-2011-1-E00027 ) funded by the National Research Foundation of Korea (NRF) for J.K. L.


  • Cross-linking
  • Gelatin microsphere
  • MCAO
  • Neuroprotection
  • Osteopontin


Dive into the research topics of 'Biodegradable gelatin microspheres enhance the neuroprotective potency of osteopontin via quick and sustained release in the post-ischemic brain'. Together they form a unique fingerprint.

Cite this